Biosite(R) Incorporated to Conduct 2nd Quarter Results Conference Call

Search Blogs that Mention this News Release

Click this link to view linked Bookmarking Services

Click this link to view linked Blogging Services

Biosite(R) Incorporated to Conduct 2nd Quarter Results Conference Call

    SAN DIEGO, July 14 /PRNewswire-FirstCall/ -- Biosite Incorporated
(Nasdaq: BSTE) announces the following Webcast:
    Biosite Incorporated will announce 2005 second quarter results on Tuesday,
July 26, 2005 following the close of the market.  The Company will also
webcast a conference call on the same day (July 26) at 1:30 p.m. Pacific.

     What:          Biosite Announces 2nd Quarter Results Conference Call

     When:          Tuesday, July 26, 2005 at 1:30 p.m. Pacific

     Where:         http://phx.corporate-ir.net/phoenix.zhtml?p=irol-
eventDetails&c=69046&eventID=1100191

                    OR http://www.biosite.com

     How:           Live over the Internet -- Simply log onto the web at the
                    address above.

     Telephonic:    US/Canada/Int'l Dial #: (706) 634-7088
                    Conference ID# 7772745

                    You may dial *0 at any time for Operator assistance

     Contact:       Simona Dixon
                    Corporate and Investor Relations
                    Biosite Incorporated
                    858.455.4808 ext. 3221
                    email: sdixon@biosite.com

     If you are unable to participate during the live webcast, the call will
be archived on the Biosite web site http://www.biosite.com until August 16th, 2005.
The telephone replay number for U.S. callers is 800-642-1687.  International
callers can dial 706-645-9291, conference ID# 7772745.

    Company press releases may be found at http://www.biosite.com

    About Biosite: A leader in the drive to advance diagnosis, Biosite
Incorporated is a research-based company dedicated to the discovery and
development of novel protein-based diagnostic tests that improve a physician's
ability to diagnose debilitating and life-threatening diseases.  The Company
combines integrated discovery and diagnostics businesses to access proteomics
research, identify proteins with high diagnostic utility, develop and
commercialize products and educate the medical community on new diagnostic
approaches that improve health care outcomes.  Biosite's Triage(R) brand rapid
diagnostic tests are used in approximately 50 percent of U.S. hospitals and in
more than 50 international markets. Biosite's commercialized products include
the Triage BNP Test to aid in the diagnosis and severity assessment of heart
failure, the Triage Cardiac Panel to aid in the diagnosis of heart attacks and
the Triage Drugs of Abuse Products for the diagnosis of drug overdose. These
tests can deliver critical diagnostic information to physicians within 10 to
20 minutes.  Information about Biosite can be found at http://www.biosite.com.

    (Minimum Requirements to listen to broadcast:  The Windows Media Player
software, downloadable free from:
http://www.microsoft.com/windows/windowsmedia/EN/default.asp
and at least a 28.8Kbps connection to the Internet.)

SOURCE Biosite Incorporated

http://www.biosite.com
Company News On-Call:

http://www.prnewswire.com/comp/116737.html
CONTACT:
Nadine Padilla, VP, Corporate & Investor
Relations of Biosite Incorporated, +1-858-455-4808, ext. 3187,
npadilla@biosite.com